Mesenchymal Stem Cells in the Musculoskeletal System: From Animal Models to Human Tissue Regeneration?

Stem Cell Reviews and Reports

Volumn 14, Issue 3, 2018, Pages 346-369

  Čamernik, Klemen ^a   Barlič, Ariana ^b   Drobnič, Matej ^c   Marc, Janja ^a   Jeras, Matjaž ^a   Zupan, Janja ^a  

^a UNIVERSITY OF LJUBLJANA   (Slovenia)

^b EDUCELL Cell Therapy Service   (Slovenia)

^c UNIVERSITY MEDICAL CENTRE LJUBLJANA   (Slovenia)

Author keywords

Bone; Mesenchymal stem cells; Muscles; Musculoskeletal system; Osteoarthritis; Osteoporosis; Regenerative medicine; Synovium

Indexed keywords

AGGRECAN; NESTIN;

ANTERIOR CRUCIATE LIGAMENT; ANTIINFLAMMATORY ACTIVITY; CARTILAGE DEGENERATION; CELL ISOLATION; CELL SUBPOPULATION; CLINICAL PRACTICE; DUCHENNE MUSCULAR DYSTROPHY; EARLY DIAGNOSIS; FRACTURE; HUMAN; MESENCHYMAL STEM CELL; MUSCLE INJURY; MUSCULOSKELETAL DISEASE; NONHUMAN; OSTEOARTHRITIS; OSTEOPOROSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RANDOMIZED CONTROLLED TRIAL (TOPIC); REGENERATIVE MEDICINE; REVIEW; SARCOPENIA; SYNOVIAL FLUID; SYNOVIUM; TENDON INJURY; TISSUE DEGENERATION; TISSUE REGENERATION; CHONDROCYTE; CYTOLOGY; MESENCHYMAL STEM CELL TRANSPLANTATION; METABOLISM; MUSCULOSKELETAL SYSTEM; PROCEDURES; TISSUE ENGINEERING;

CHONDROCYTES; HUMANS; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STEM CELLS; MUSCULOSKELETAL SYSTEM; REGENERATIVE MEDICINE; SYNOVIAL MEMBRANE; TISSUE ENGINEERING;

EID: 85046022835     PISSN: 15508943     EISSN: 15586804     Source Type: Journal    
DOI: 10.1007/s12015-018-9800-6     Document Type: Review

References (189)

1. Walmsley, G. G., Ransom, R. C., Zielins, E. R., et al. (2015). Stem cells in bone regeneration. Stem Cell Reviews and Reports. 10.1007/s12015-016-9665-5.
2. Tedesco, F. S., Dellavalle, A., Diaz-Manera, J., Messina, G., & Cossu, G. (2010). Repairing skeletal muscle: regenerative potential of skeletal muscle stem cells. Journal of Clinical Investigation. 10.1172/JCI40373.
3. Friedenstein, A. J., Chailakhjan, R. K., & Lalykina, K. S. (1970). The development of a fibroblast colonies in monolayer cultures of guinea pig bone marrow and spleen cells. Cell Proliferation. 10.1111/j.1365-2184.1970.tb00347.x.
4. Pittenger, M., Mackay, A., Beck, S., et al. (1999). Multilineage potential of adult human mesenchymal stem cells. Science. 10.1126/science.284.5411.143.
5. Hass, R., Kasper, C., Böhm, S., & Jacobs, R. (2011). Different populations and sources of human mesenchymal stem cells (MSCs): a comparison of adult and neonatal tissue-derived MSC. Cell Communication and Signaling: CCS. 10.1186/1478-811X-9-12.
6. Grcevic, D., Pejda, S., Matthews, B. G., et al. (2012). In vivo fate mapping identifies mesenchymal progenitor cells. Stem Cells. 10.1002/stem.780.
7. Tuli, R., Seghatoleslami, M. R., Tuli, S., et al. (2003). A simple, high-yield method for obtaining multipotential mesenchymal progenitor cells from trabecular bone. Molecular Biotechnology. 10.1385/MB:23:1:37.
8. Worthley, D. L., Churchill, M., Compton, J. T., et al. (2015). Gremlin 1 identifies a skeletal stem cell with bone, cartilage, and reticular stromal potential. Cell. 10.1016/j.cell.2014.11.042.
9. Méndez-Ferrer, S., Michurina, T. V., Ferraro, F., et al. (2010). Mesenchymal and haematopoietic stem cells form a unique bone marrow niche. Nature. 10.1038/nature09262.
10. Zhou, B. O., Yue, R., Murphy, M. M., Peyer, J. G., & Morrison, S. J. (2014). Leptin-receptor-expressing mesenchymal stromal cells represent the main source of bone formed by adult bone marrow. Cell Stem Cell. 10.1016/j.stem.2014.06.008.
11. Chan, C. K. F., Seo, E. Y., Chen, J. Y., et al. (2015). Identification and specification of the mouse skeletal stem cell. Cell. 10.1016/j.cell.2014.12.002.
12. De Bari, C., Dell’Accio, F., Tylzanowski, P., Luyten, F. P. (2001) Multipotent mesenchymal stem cells from adult human synovial membrane. Arthritis and Rheumatism, 10.1002/1529-0131(200108)44:8<1928::AID-ART331>3.0.CO;2-P
13. Sakaguchi, Y., Sekiya, I., Yagishita, K., & Muneta, T. (2005). Comparison of human stem cells derived from various mesenchymal tissues: superiority of synovium as a cell source. Arthritis and Rheumatism. 10.1002/art.21212.
14. Roelofs, A. J., Zupan, J., Riemen, A. H. K., et al. (2017). Joint morphogenetic cells in the adult synovium. Nature Communications. 10.1038/ncomms15040.
15. Kurth, T. B., Dell’Accio, F., Crouch, V., Augello, A., Sharpe, P. T., & De Bari, C. (2011). Functional mesenchymal stem cell niches in adult mouse knee joint synovium in vivo. Arthritis and Rheumatism. 10.1002/art.30234.
16. Tan, Q., Lui, P. P., Rui, Y. F., & Wong, Y. M. (2012). Comparison of potentials of stem cells isolated from tendon and bone marrow for musculoskeletal tissue engineering. Tissue Engineering Part A. 10.1089/ten.TEA.2011.0362.
17. Lui, P. P. (2015). Markers for the identification of tendon-derived stem cells in vitro and tendon stem cells in situ – update and future development. Stem Cell Research & Therapy. 10.1186/s13287-015-0097-y.
18. Sienkiewicz, D., Kulak, W., Okurowska-Zawada, B., Paszko-Patej, G., Kawnik, K (2015). Duchenne muscular dystrophy: current cell therapies. Therapeutic Advances in Neurological Disorders. 10.1177/1756285615586123.
19. De Bari, C., Dell’Accio, F., Vandenabeele, F., Vermeesch, J. R., Raymackers, J. M., & Luyten, F. P. (2003). Skeletal muscle repair by adult human mesenchymal stem cells from synovial membrane. The Journal of Cell Biology. 10.1083/jcb.200212064.
20. Chen, C., Qu, Z., Yin, X., et al. (2016). Efficacy of umbilical cord-derived mesenchymal stem cell-based therapy for osteonecrosis of the femoral head: a three-year follow-up study. Molecular Medicine Reports. 10.3892/mmr.2016.5745.
21. Daltro, G. C., Fortuna, V., de Souza, E. S., et al. (2012). Efficacy of autologous stem cell-based therapy for osteonecrosis of the femoral head in sickle cell disease: a five-year follow-up study. Stem Cell Research & Therapy. 10.1186/s13287-015-0105-2.
22. Aoyama, T., Goto, K., Kakinoki, R., et al. (2014). An exploratory clinical trial for idiopathic osteonecrosis of femoral head by cultured autologous multipotent mesenchymal stromal cells augmented with vascularized bone grafts. Tissue Engineering Part B. 10.1089/ten.teb.2014.0090.
23. Rastogi, S., Sankineani, S. R., Nag, H. L., et al. (2013). Intralesional autologous mesenchymal stem cells in management of osteonecrosis of femur: a preliminary study. Musculoskeletal Surgery. 10.1007/s12306-013-0273-0.
24. Zhao, D., Cui, D., Wang, B., et al. (2012). Treatment of early stage osteonecrosis of the femoral head with autologous implantation of bone marrow-derived and cultured mesenchymal stem cells. Bone. 10.1016/j.bone.2011.11.002.
25. Weel, H., Mallee, W. H., van Dijk, C. N., et al. (2015). The effect of concentrated bone marrow aspirate in operative treatment of fifth metatarsal stress fractures; a double-blind randomized controlled trial. BMC Musculoskeletal Disorders. 10.1186/s12891-015-0649-4.
26. Wong, K. L., Lee, K. B., Tai, B. C., Law, P., Lee, E. H., & Hui, J. H. (2013). Injectable cultured bone marrow-derived mesenchymal stem cells in varus knees with cartilage defects undergoing high tibial osteotomy: a prospective, randomized controlled clinical trial with two years’ follow-up. Arthroscopy. 10.1016/j.arthro.2013.09.074.
27. Pers, Y.-M., Rackwitz, L., Ferreira, R., et al. (2016). Adipose mesenchymal stromal cell-based therapy for severe osteoarthritis of the knee: a phase I dose-escalation trial. Stem Cells Translational Medicine. 10.5966/sctm.2015-0245.
28. Orozco, L., Munar, A., Soler, R., et al. (2013). Treatment of knee osteoarthritis with autologous mesenchymal stem cells. Transplantation. 10.1097/TP.0b013e318291a2da.
29. Freitag, J., Ford, J., Bates, D., et al. (2015). Adipose derived mesenchymal stem cell therapy in the treatment of isolated knee chondral lesions: design of a randomised controlled pilot study comparing arthroscopic microfracture versus arthroscopic microfracture combined with postoperative mesenchymal. British Medical Journal Open. 10.1136/bmjopen-2015-009332.
30. Jo, C., Lee, Y., & Shin, W. (2014). Intra-articular injection of mesenchymal stem cells for the treatment of osteoarthritis of the knee: a proof-of-concept clinical trial. Stem Cells. 10.1002/stem.1634.
31. Davatchi, F., Sadeghi Abdollahi, B., Mohyeddin, M., Nikbin, B. (2016). Mesenchymal stem cell therapy for knee osteoarthritis: five years follow-up of three patients. International Journal Rheumatic Diseases. 10.1111/1756-185X.12670.
32. Davatchi, F., Abdollahi, B. S., Mohyeddin, M., Shahram, F., & Nikbin, B. (2011). Mesenchymal stem cell therapy for knee osteoarthritis. Preliminary report of four patients. International Journal Rheumatic Diseases. 10.1111/j.1756-185X.2011.01599.x.
33. Vega, A., Martín-Ferrero, M. A., Del Canto, F., et al. (2015). Treatment of knee osteoarthritis with allogeneic bone marrow mesenchymal stem cells. Transplantation. 10.1097/TP.0000000000000678.
34. Vangsness, C. T., Farr, J., Boyd, J., Dellaero, D. T., Mills, C. R., & LeRoux-Williams, M. (2014). Adult human mesenchymal stem cells delivered via intra-articular injection to the knee following partial medial menisectomy. The Journal of Bone and Joint Surgery. 10.2106/JBJS.M.00058.
35. Centeno, C. J., Al-Sayegh, H., Bashir, J., Goodyear, S. H., & Freeman, M. D. (2015). A prospective multi-Site registry study of a specific protocol of autologous bone marrow concentrate for the treatment of shoulder rotator cuff tears and osteoarthritis. Journal of Pain Research. 10.2147/JPR.S80872.
36. Centeno, C. J., Busse, D., Kisiday, J., et al. (2008). Increased knee cartilage volume in degenerative joint disease using percutaneously implanted, autologous mesenchymal stem cells. Pain Physician, 11(3), 343–353.
37. Akgun, I., Unlu, M. C., Erdal, O. A., et al. (2015). Matrix-induced autologous mesenchymal stem cell implantation versus matrix-induced autologous chondrocyte implantation in the treatment of chondral defects of the knee: a 2-year randomized study. Archives of Orthopaedic and Trauma Surgery. 10.1007/s00402-014-2136-z.
38. Koh, Y.-G., Kwon, O.-R., Kim, Y.-S., Choi, Y.-J., & Tak, D.-H. (2016). Adipose-derived mesenchymal stem cells with microfracture versus microfracture alone: two-year follow-up of a prospective randomized trial. Arthroscopy. 10.1016/j.arthro.2015.09.010.
39. Chamberlain, C. S., Saether, E. E., Aktas, E., & Vanderby, R. (2017). Mesenchymal stem cell therapy on tendon/ ligament healing. Journal of Cytokine Biology, 2(1), 112.
40. Lee, S. Y., Kim, W., Lim, C., & Chung, S. G. (2015). Treatment of lateral epicondylosis by using allogenic adipose-derived mesenchymal stem cells: a pilot study. Stem Cells. 10.1002/stem.2110.
41. Kim, S. J., Song, D. H., Park, J. W., Park, S., & Kim, S. J. (2017). Effect of bone marrow aspirate concentrate-platelet-rich plasma on tendon-derived stem cells and rotator cuff tendon tear. Cell Transplantation. 10.3727/096368917X694705.
42. Alsalameh, S., Amin, R., Gemba, T., & Lotz, M. (2004). Identification of mesenchymal progenitor cells in normal and osteoarthritic human articular cartilage. Arthritis and Rheumatism. 10.1002/art.20269.
43. Pretzel, D., Linss, S., Rochler, S., et al. (2011). Relative percentage and zonal distribution of mesenchymal progenitor cells in human osteoarthritic and normal cartilage. Arthritis Research and Therapy. 10.1186/ar3320.
44. Williams, R., Khan, I. M., Richardson, K., et al. (2010). Identification and clonal characterisation of a progenitor cell sub-population in normal human articular cartilage. PLoS One. 10.1371/journal.pone.0013246.
45. Sacchetti, B., Funari, A., Remoli, C., et al. (2016). No identical “mesenchymal stem cells” at different times and sites: human committed progenitors of distinct origin and differentiation potential are incorporated as adventitial cells in microvessels. Stem Cell Reports. 10.1016/j.stemcr.2016.05.011.
46. Al-Nbaheen, M., Vishnubalaji, R., Ali, D., et al. (2013). Human stromal (mesenchymal) stem cells from bone marrow, adipose tissue and skin exhibit differences in molecular phenotype and differentiation potential. Stem Cell Reviews and Reports. 10.1007/s12015-012-9365-8.
47. Crisan, M., Yap, S., Casteilla, L., Chen, C. W., et al. (2008). A perivascular origin for mesenchymal stem cells in multiple human organs. Cell Stem Cell. 10.1016/j.stem.2008.07.003.
48. Guimarães-Camboa, N., Cattaneo, P., Sun, Y., et al. (2017). Pericytes of multiple organs do not behave as mesenchymal stem cells in vivo. Cell Stem Cell. 10.1016/j.stem.2016.12.006.
49. Murphy, J. M., Dixon, K., Beck, S., Fabian, D., Feldman, A., & Barry, F. (2002). Reduced chondrogenic and adipogenic activity of mesenchymal stem cells from patients with advanced osteoarthritis. Arthritis and Rheumatism. 10.1002/art.10118.
50. Sakaguchi, Y., Sekiya, I., Yagishita, K., Ichinose, S., Shinomiya, K., & Muneta, T. (2009). Suspended cells from trabecular bone by collagenase digestion become virtually identical to mesenchymal stem cells obtained from marrow. Stem Cells. 10.1182/blood-2003-12-4452.
51. Latil, M., Rocheteau, P., Châtre, L., et al. (2012). Skeletal muscle stem cells adopt a dormant cell state post mortem and retain regenerative capacity. Nature Communications. 10.1038/ncomms1890.
52. Valente, S., Alviano, F., Ciavarella, C., et al. (2014). Human cadaver multipotent stromal/stem cells isolated from arteries stored in liquid nitrogen for 5 years. Stem Cell Research & Therapy. 10.1186/scrt397.
53. Baustian, C., Hanley, S., & Ceredig, R. (2012). Isolation, selection and culture methods to enhance clonogenicity of mouse bone marrow derived mesenchymal stromal cell precursors. Stem Cell Research & Therapy. 10.1186/s13287-015-0139-5.
54. Futami, I., Ishijima, M., Kaneko, H., et al. (2012). Isolation and characterization of multipotential mesenchymal cells from the mouse synovium. PLoS One. 10.1371/journal.pone.0045517.
55. Zhu, H., Guo, Z.-K., Jiang, X.-X., et al. (2010). A protocol for isolation and culture of mesenchymal stem cells from mouse compact bone. Nature Protocols. 10.1038/nprot.2009.238.
56. Tsai, C.-C., Yew, T.-L., Yang, D.-C., Huang, W.-H., & Hung, S.-C. (2012) Benefits of hypoxic culture on bone marrow multipotent stromal cells. American Journal of Blood Research.
57. Dominici, M., Le Blanc, K., Mueller, I., et al. (2006) Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy. 10.1080/14653240600855905.
58. Fuchs, E., & Horsley, V. (2011). Ferreting out stem cells from their niches. Nature Cell Biology. 10.1038/ncb0511-513.
59. Morikawa, S., Mabuchi, Y., Kubota, Y., et al. (2009). Prospective identification, isolation, and systemic transplantation of multipotent mesenchymal stem cells in murine bone marrow. The Journal of Experimental Medicine. 10.1084/jem.20091046.
60. Pinho, S., Lacombe, J., Hanoun, M., et al. (2013). PDGFRa and CD51 mark human Nestin + sphere-forming mesenchymal stem cells capable of hematopoietic progenitor cell expansion. The Journal of Experimental Medicine. 10.1084/jem.20122252.
61. Park, D., Spencer, J. A., Koh, B. I., et al. (2012). Cell stem cell endogenous bone marrow MSCs are dynamic, fate-restricted participants in bone maintenance and regeneration. Stem Cell. 10.1016/j.stem.2012.02.003.
62. Mizoguchi, T., Pinho, S., Ahmed, J., et al. (2014). Osterix marks distinct waves of primitive and definitive stromal progenitors during bone marrow development. Developmental Cell. 10.1016/j.devcel.2014.03.013.
63. Liu, Y., Strecker, S., Wang, L., et al. (2013). Osterix-Cre labeled progenitor cells contribute to the formation and maintenance of the bone marrow stroma. PLoS One. 10.1371/journal.pone.0071318.
64. Marecic, O., Tevlin, R., McArdle, A., et al. (2015). Identification and characterization of an injury-induced skeletal progenitor. Proceedings of the National Academy of Sciences. 10.1073/pnas.1513066112.
65. Tanaka, K. K., Hall, J. K., Troy, A. A., Cornelison, D. D. W., Majka, S. M., & Olwin, B. B. (2009). Syndecan-4-expressing muscle progenitor cells in the SP engraft as satellite cells during muscle regeneration. Cell Stem Cell. 10.1016/j.stem.2009.01.016.
66. Doyle, M. J., Zhou, S., Tanaka, K. K., et al. (2011). Abcg2 labels multiple cell types in skeletal muscle and participates in muscle regeneration. The Journal of Cell Biology. 10.1083/jcb.201103159.
67. Meeson, A. P., Hawke, T. J., Graham, S., et al. (2004). Cellular and molecular regulation of skeletal muscle side population cells. Stem Cells. 10.1634/stemcells.2004-0077.
68. Penton, C. M., Thomas-Ahner, J. M., Johnson, E. K., McAllister, C., & Montanaro, F. (2013). Muscle side population cells from dystrophic or injured muscle adopt a fibro-adipogenic fate. PLoS One. 10.1371/journal.pone.0054553.
69. Pannérec, A., Formicola, L., Besson, V., Marazzi, G., & Sassoon, D. A. (2013). Defining skeletal muscle resident progenitors and their cell fate potentials. Development. 10.1242/dev.089326.
70. Cottle, B. J., Lewis, F. C., Shone, V., & Ellison-Hughes, G. M. (2017). Skeletal muscle-derived interstitial progenitor cells (PICs) display stem cell properties, being clonogenic, self-renewing, and multi-potent in vitro and in vivo. Stem Cell Research & Therapy. 10.1186/s13287-017-0612-4.
71. Mitchell, K. J., Pannerec, A., Cadot, B., et al. (2010). Identification and characterization of a non-satellite cell muscle resident progenitor during postnatal development. Nature Cell Biol. 10.1038/ncb2025.
72. Lewis, F. C., Henning, B. J., Marazzi, G., Sassoon, D., Ellison, G. M., & Nadal-Ginard, B. (2014). Porcine skeletal-muscle-derived multipotent PW1 pos /Pax7 neg interstitial cells: isolation, characterization, and long-term culture. Stem Cells Transational Medicine. 10.5966/sctm.2013-0174.
73. Bosnakovski, D., Xu, Z., Li, W., et al. (2008). Prospective isolation of skeletal muscle stem cells with a Pax7 reporter. Stem Cells. 10.1634/stemcells.2007-1017.
74. Seale, P., Sabourin, L. A., Girgis-Gabardo, A., Mansouri, A., Gruss, P., & Rudnicki, M. A. (2000) Pax7 is required for the specification of myogenic satellite cells skeletal muscle. Cell, 102(6), 777–786.
75. Xu, X., Wilschut, K. J., Kouklis, G., et al. (2015). Human satellite cell transplantation and regeneration from diverse skeletal muscles. Stem Cell Reports. 10.1016/j.stemcr.2015.07.016.
76. Morosetti, R., Mirabella, M., Gliubizzi, C., et al. (2007). Isolation and characterization of mesoangioblasts from facioscapulohumeral muscular dystrophy muscle biopsies. Stem Cells. 10.1634/stemcells.2007-0465.
77. Bonfanti, C., Rossi, G., Tedesco, F. S., et al. (2015). ARTICLE PW1/Peg3 expression regulates key properties that determine mesoangioblast stem cell competence. Nature Communications. 10.1038/ncomms7364.
78. Morosetti, R., Mirabella, M., Gliubizzi, C., et al. (2006). MyoD expression restores defective myogenic differentiation of human mesoangioblasts from inclusion-body myositis muscle. Proceeding of the National Academy of Sciences. 10.1073/pnas.0603386103.
79. Dellavalle, A., Maroli, G., Covarello, D., et al. (2011). Pericytes resident in postnatal skeletal muscle differentiate into muscle fibres and generate satellite cells. Nature Communications. 10.1038/ncomms1508.
80. Birbrair, A., Zhang, T., Wang, Z. M., et al. (2013). Role of pericytes in skeletal muscle regeneration and fat accumulation. Stem Cells and Development. 10.1089/scd.2012.0647.
81. Dellavalle, A., Sampaolesi, M., Tonlorenzi, R., et al. (2007) Pericytes of human skeletal muscle are myogenic precursors distinct from satellite cells. Nature Cell Biology, 10.1038/ncb1542.
82. Uezumi, A., Ito, T., Morikawa, D., et al. (2011). Fibrosis and adipogenesis originate from a common mesenchymal progenitor in skeletal muscle. Journal of Cell Science. 10.1242/jcs.086629.
83. Uezumi, A., Fukada, S., Yamamoto, N., Takeda, S., & Tsuchida, K. (2010). Mesenchymal progenitors distinct from satellite cells contribute to ectopic fat cell formation in skeletal muscle. Nature Cell Biology. 10.1038/ncb2014.
84. Uezumi, A., Fukada, S., Yamamoto, N., et al. (2014). Identification and characterization of PDGFRa + mesenchymal progenitors in human skeletal muscle. Cell Death & Disease. 10.1038/cddis.2014.161.
85. Arrighi, N., Moratal, C., Clément, N., et al. (2015). Characterization of adipocytes derived from fibro/adipogenic progenitors resident in human skeletal muscle. Cell Death & Disease. 10.1038/cddis.2015.79.
86. Joe, A. W., Yi, L., Natarajan, A., et al. (2010). Muscle injury activates resident fibro/adipogenic progenitors that facilitate myogenesis. Nature Cell Biology. 10.1038/ncb2015.
87. Xu, W., Sun, Y., Zhang, J., et al. (2015). Perivascular-derived stem cells with neural crest characteristics are involved in tendon repair. Stem Cells and Development. 10.1089/scd.2014.0036.
88. Runesson, E., Ackermann, P., Karlsson, J., & Eriksson, B. I. (2015). A randomised controlled trial of percutaneous fixation with kirschner wires versus volar locking-plate fixation in the treatment of adult patients with a dorsally displaced fracture of the distal radius. BMC Musculoskeletal Disorders. 10.1186/s12891-015-0658-3.
89. Donahue, T., Gregersen, C., Hull, M., et al. (2015). Harnessing endogenous stem/progenitor cells for tendon regeneration. Journal of Biomechanical Engineering. 10.1172/JCI81589.
90. Dyment, N. A., Hagiwara, Y., Matthews, B. G., Li, Y., Kalajzic, I., & Rowe, D. W. (2014). Lineage tracing of resident tendon progenitor cells during growth and natural healing. PLoS One. 10.1371/journal.pone.0096113.
91. Fukada, S., Higuchi, S., Segawa, M., et al. (2004). Purification and cell-surface marker characterization of quiescent satellite cells from murine skeletal muscle by a novel monoclonal antibody. Experimental Cell Research. 10.1016/j.yexcr.2004.02.018.
92. Kuyinu, E. L., Narayanan, G., Nair, L. S., & Laurencin, C. T. (2016). Animal models of osteoarthritis: classification, update, and measurement of outcomes. Journal of Orthopaedic Surgery and Research. 10.1186/s13018-016-0346-5.
93. Mills, L. A., & Simpson, A. H. (2012). In vivo models of bone repair. Bone Joint and Journal. 10.1302/0301-620X.94B7.27370.
94. Hardy, D., Besnard, A., Latil, M., et al. (2016). Comparative study of injury models for studying muscle regeneration in mice. PLoS One. 10.1371/journal.pone.0147198.
95. Carpenter, J. E., & Hankenson, K. D. (2004). Animal models of tendon and ligament injuries for tissue engineering applications. Biomaterials. 10.1016/S0142-9612(03)00507-6.
96. Docheva, D., Müller, S. A., Majewski, M., & Evans, C. H. (2015). Biologics for tendon repair. Advanced Drug Delivery Reviews. 10.1016/j.addr.2014.11.015.
97. Hast, M. W., Zuskov, A., & Soslowsky, L. J. (2014). The role of animal models in tendon research. Bone and Joint Research. 10.1302/2046-3758.36.2000281.
98. Kfoury, Y., & Scadden, D. T. (2015). Cell stem cell mesenchymal cell contributions to the stem cell niche. Stem Cells. 10.1016/j.stem.2015.02.019.
99. Omatsu, Y., Seike, M., Sugiyama, T., Kume, T., & Nagasawa, T. (2014). Foxc1 is a critical regulator of haematopoietic stem/ progenitor cell niche formation. Nature. 10.1038/nature13071.
100. Isern, J., Martín-Antonio, B., Ghazanfari, R., et al. (2013). Self-renewing human bone marrow mesenspheres promote hematopoietic stem cell expansion. Cell Reports. 10.1016/j.celrep.2013.03.041.
101. Ding, L., Saunders, T. L., Enikolopov, G., & Morrison, S. J. (2012). Endothelial and perivascular cells maintain haematopoietic stem cells. Nature. 10.1038/nature10783.
102. Kunisaki, Y., Bruns, I., Scheiermann, C., et al. (2013). Arteriolar niches maintain haematopoietic stem cell quiescence. Nature. 10.1038/nature12612.
103. Fernandez-Moure, J. S., Corradetti, B., Chan, P., et al. (2015). Enhanced osteogenic potential of mesenchymal stem cells from cortical bone: a comparative analysis. Stem Cell Research & Therapy. 10.1186/s13287-015-0193-z.
104. Li, H., Ghazanfari, R., Zacharaki, D., et al. (2014). Low/ negative expression of PDGFR-α identifies the candidate primary mesenchymal stromal cells in adult human bone marrow. Stem Cell Reports. 10.1016/j.stemcr.2014.09.018.
105. Campbell, T. M., Churchman, S. M., Gomez, A., et al. (2016). Mesenchymal stem cell alterations in bone marrow lesions in patients with hip osteoarthritis. Arthritis & Rheumatology. 10.1002/art.39622.
106. Lee, W. C., Shi, H., Poon, Z., et al. (2014). Multivariate biophysical markers predictive of mesenchymal stromal cell multipotency. Proceedings of the National Academy of Science. 10.1073/pnas.1402306111.
107. Johnson, K., Zhu, S., Tremblay, M. S., et al. (2013). A stem-cell–based approach to cartilage repair. Science. 10.1126/science.1229223.
108. Mauro, A. (1961). Satellite cell of skeletal muscle fibers. The Journal of Biophysical and Biochemical Cytology. 10.1083/jcb.9.2.493.
109. Muir, A. R., Kanji, A. H., & Allbrook, D. (1965). The structure of the satellite cells in skeletal muscle. Journal of Anatomy, 99(Pt 3), 435–444.
110. Goodell, M. A., Brose, K., Paradis, G., Conner, A. S., & Mulligan, R. C. (1996). Isolation and functional properties of murine hematopoietic stem cells that are replicating in vivo. The Journal of Experimental Medicine. 10.1084/jem.183.4.1797.
111. Montanaro, F., Liadaki, K., Schienda, J., Flint, A., Gussoni, E., & Kunkel, L. M. (2004). Demystifying SP cell purification: Viability, yield, and phenotype are defined by isolation parameters. Experimental Cell Research. 10.1016/j.yexcr.2004.04.010.
112. Uezumi, A., Ojima, K., Fukada, S., et al. (2006). Functional heterogeneity of side population cells in skeletal muscle. Biochemical and Biophysical Research Communications. 10.1016/j.bbrc.2006.01.037.
113. Zhou, S., Schuetz, J. D., Bunting, K. D., et al. (2001). The ABC transporter Bcrp1/ABCG2 is expressed in a wide variety of stem cells and is a molecular determinant of the side-population phenotype. Nature Medicine. 10.1038/nm0901-1028.
114. Asakura, A., Seale, P., Girgis-Gabardo, A., & Rudnicki, M. A. (2002). Myogenic specification of side population cells in skeletal muscle. The Journal of Cell Biology. 10.1083/jcb.200202092.
115. Sampaolesi, M., Torrente, Y., Innocenzi, A., et al. (2003). Cell therapy of α-sarcoglycan-null dystrophic mice through intra-arterial delivery of mesoangioblasts. Science. 10.1126/science.1082254.
116. Galvez, B. G., Sampaolesi, M., Brunelli, S., et al. (2006). Complete repair of dystrophic skeletal muscle by mesoangioblasts with enhanced migration ability. The Journal of Cell Biology. 10.1083/jcb.200512085.
117. Sampaolesi, M., Blot, S., D’Antona, G., et al. (2006). Mesoangioblast stem cells ameliorate muscle function in dystrophic dogs. Nature. 10.1038/nature05282.
118. Cossu, G., Previtali, S. C., Napolitano, S., et al. (2015). Intra-arterial transplantation of HLA-matched donor mesoangioblasts in Duchenne muscular dystrophy. EMBO Molecular Medicine. 10.15252/emmm.201505636.
119. Relaix, F., & Zammit, P. S. (2012). Satellite cells are essential for skeletal muscle regeneration: the cell on the edge returns centre stage. Development. 10.1242/dev.069088.
120. Sambasivan, R., Yao, R., Kissenpfennig, A., Van Wittenberghe, L., et al. (2011). Pax7-expressing satellite cells are indispensable for adult skeletal muscle regeneration. Development. 10.1242/dev.067587.
121. Hernandez-Torres, F., Rodríguez-Outeiriño, L., Franco, D., & Aranega, A. E. (2017). Pitx2 in embryonic and adult myogenesis. Frontiers in Cell and Development Biology. 10.3389/fcell.2017.00046.
122. Zhang, J., & Wang, J. (2013). Human tendon stem cells better maintain their stemness in hypoxic culture conditions. PLoS One. 10.1371/journal.pone.0061424.
123. Bi, Y., Ehirchiou, D., Kilts, T. M., et al. (2007). Identification of tendon stem/progenitor cells and the role of the extracellular matrix in their niche. Nature Medicine. 10.1038/nm1630.
124. Po, P., & Lui, Y. (2015). Stem cell technology for tendon regeneration: current status, challenges, and future research directions. Stem Cells Cloning: Advances and Applications. 10.2147/SCCAA.S60832.
125. Zhang, X., Lin, Y. C., Rui, Y. F., et al. (2016). Therapeutic roles of tendon stem/ progenitor cells in tendinopathy. Stem Cells International. 10.1155/2016/4076578.
126. Lee, K. J., Clegg, P. D., Comerford, E. J., & Canty-Laird, E. G. (2017). Ligament-derived stem cells: identification, characterisation, and therapeutic application. Stem Cells International. 10.1155/2017/1919845.
127. Cheng, M. T., Yang, H. W., Chen, T. H., & Lee, O. K. (2009). Isolation and characterization of multipotent stem cells from human cruciate ligaments. Cell Proliferation. 10.1111/j.1365-2184.2009.00611.x.
128. de Sousa, E., Casado, P., Neto, V., Duarte, M. E., & Aguiar, D. (2014). Synovial fluid and synovial membrane mesenchymal stem cells: latest discoveries and therapeutic perspectives. Stem Cell Research & Therapy. 10.1186/scrt501.
129. Spees, J. L., Lee, R. H., & Gregory, C. A. (2016). Mechanisms of mesenchymal stem/stromal cell function. Stem Cell Research & Therapy. 10.1186/s13287-016-0363-7.
130. Zachar, L., Bačenková, D., & Rosocha, J. (2016). Activation, homing, and role of the mesenchymal stem cells in the inflammatory environment. Journal of Inflammation Research. 10.2147/JIR.S121994.
131. Schepers, K., & Fibbe, W. E. (2016). Unraveling mechanisms of mesenchymal stromal cell-mediated immunomodulation through patient monitoring and product characterization. Annals of the New York Academy of Sciences. 10.1111/nyas.12984.
132. Zhao, Q., Ren, H., & Han, Z. (2016). Mesenchymal stem cells: Immunomodulatory capability and clinical potential in immune diseases. Journal of Cellular Immunotherapy. 10.1016/j.jocit.2014.12.001.
133. Regulski, M. J. (2017). Mesenchymal stem cells: “guardians of inflammation.” Wounds, 29, 20–27.
134. Nishizawa, K., & Seki, R. (2016). Mechanisms of immunosuppression by mesenchymal stromal cells: a review with a focus on molecules. Biomedical Research and Clinical Practice. 10.15761/BRCP.1000116.
135. Glenn, J. D. (2014). Mesenchymal stem cells: emerging mechanisms of immunomodulation and therapy. World Journal of Stem Cells. 10.4252/wjsc.v6.i5.526.
136. Gruh, I., & Martin, U. (2009). Transdifferentiation of stem cells: a critical view. Engineering of Stem Cells. 10.1007/10_2008_49.
137. Prockop, D. J., & Oh, J. Y. (2012). Medical therapies with adult stem/progenitor cells (MSCs): a backward journey from dramatic results in vivo to the cellular and molecular explanations. Journal of Cellular Biochemistry. 10.1002/jcb.24046.
138. Sottile, F., Aulicino, F., Theka, I., & Cosma, M. P. (2016). Mesenchymal stem cells generate distinct functional hybrids in vitro via cell fusion or entosis. Scientific Reports. 10.1038/srep36863.
139. Usunier, B., Benderitter, M., Tamarat, R., & Chapel, A. (2014). Management of fibrosis: the mesenchymal stromal cells breakthrough. Stem Cells International. 10.1155/2014/340257.
140. Islam, M. N., Das, S. R., Emin, M. T., et al. (2012). Mitochondrial transfer from bone marrow-derived stromal cells to pulmonary alveoli protects against acute lung injury. Nature Medicine. 10.1038/nm.2736.
141. Chinnery, H. R., Pearlman, E., & McMenamin, P. G. (2008). Cutting edge: Membrane nanotubes in vivo: a feature of MHC class II + cells in the mouse cornea. Journal of Immunology, 180(9), 5779–5783.
142. Liu, K., Ji, K., Guo, L., et al. (2014). Mesenchymal stem cells rescue injured endothelial cells in an in vitro ischemia–reperfusion model via tunneling nanotube like structure-mediated mitochondrial transfer. Microvascular Research. 10.1016/j.mvr.2014.01.008.
143. Valadi, H., Ekström, K., Bossios, A., Sjöstrand, M., Lee, J. J., & Lötvall, J. O. (2007). Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nature Cell Biology. 10.1038/ncb1596.
144. Viganò, M., Sansone, V., d’Agostino, M. C., Romeo, P., Perucca Orfei, C., & de Girolamo, L. (2016). Mesenchymal stem cells as therapeutic target of biophysical stimulation for the treatment of musculoskeletal disorders. Journal of Orthopaedic Surgery and Research. 10.1186/s13018-016-0496-5.
145. Coelho, M. B., Cabral, J. M. S., & Karp, J. M. (2012). Intraoperative stem cell therapy. Annual Review of Biomedical Engineering. 10.1146/annurev-bioeng-071811-150041.
146. Veronesi, F., Giavaresi, G., Tschon, M., Borsari, V., Nicoli Aldini, N., & Fini, M. (2013). Clinical use of bone marrow, bone marrow concentrate, and expanded bone marrow mesenchymal stem cells in cartilage disease. Stem Cells and Development. 10.1089/scd.2012.0373.
147. Hernigou, P., Homma, Y., Flouzat Lachaniette, C.H., et al (2013). Benefits of small volume and small syringe for bone marrow aspirations of mesenchymal stem cells. International Orthopaedics. 10.1007/s00264-013-2017-z.
148. Otsuru, S., Hofmann, T. J., Olson, T. S., Dominici, M., & Horwitz, E. M. (2013). Improved isolation and expansion of bone marrow mesenchymal stromal cells using a novel marrow filter device. Cytotherapy. 10.1016/j.jcyt.2012.10.012.
149. Ito, K., Aoyama, T., Fukiage, K., et al. (2010). A novel method to isolate mesenchymal stem cells from bone marrow in a closed system using a device made by nonwoven fabric. Tissue Engineering Part C Methods. 10.1089/ten.TEC.2008.0693.
150. Zuk, P. A., Zhu, M., Mizuno, H., et al. (2001). Multilineage cells from human adipose tissue: implications for cell-based therapies. Tissue Engineering. 10.1089/107632701300062859.
151. Lendeckel, S., Jödicke, A., Christophis, P., et al. (2004). Autologous stem cells (adipose) and fibrin glue used to treat widespread traumatic calvarial defects: case report. Journal of Cranio-Maxillofacial Surgery. 10.1016/j.jcms.2004.06.002.
152. Baer, P. C., & Geiger, H. (2012). Adipose-derived mesenchymal stromal/stem cells: tissue localization, characterization, and heterogeneity. Stem Cells International. 10.1155/2012/812693.
153. Fraser, J. K., Zhu, M., Wulur, I., & Alfonso, Z. (2008). Adipose-derived stem cells. Methods in Molecular Biology. 10.1007/978-1-60327-169-1_4.
154. Pak, J., Lee, J. H., Park, K. S., Park, M., Kang, L. W., & Lee, S. H. (2017). Current use of autologous adipose tissue-derived stromal vascular fraction cells for orthopedic applications. Journal of Biomedical Sciences. 10.1186/s12929-017-0318-z.
155. Ancans, J. (2012). Cell therapy medicinal product regulatory framework in Europe and its application for MSC-based therapy development. Frontiers in Immunology. 10.3389/fimmu.2012.00253.
156. Kristjánsson, B., & Honsawek, S. (2014). Current perspectives in mesenchymal stem cell therapies for osteoarthritis. Stem Cells International. 10.1155/2014/194318.
157. Reissis, D., Tang, Q. O., Cooper, N. C., et al. (2016). Current clinical evidence for the use of mesenchymal stem cells in articular cartilage repair. Expert Opinion on Biological Therapy. 10.1517/14712598.2016.1145651.
158. Centeno, C. J., Al-Sayegh, H., Freeman, M. D., Smith, J., Murrell, W. D., & Bubnov, R. (2016). A multi-center analysis of adverse events among two thousand, three hundred and seventy two adult patients undergoing adult autologous stem cell therapy for orthopaedic conditions. International Orthopaedics. 10.1007/s00264-016-3162-y.
159. Deng, Z., Jin, J., Zhao, J., & Xu, H. (2016). Cartilage defect treatments: With or without cells? Mesenchymal stem cells or chondrocytes? Traditional or matrix-assisted? A systematic review and meta-analyses. Stem Cells International. 10.1155/2016/9201492.
160. Kon, E., Roffi, A., Filardo, G., Tesei, G., & Marcacci, M. (2015). Scaffold-based cartilage treatments: with or without cells? A systematic review of preclinical and clinical evidence. Arthroscopy. 10.1016/j.arthro.2014.11.017.
161. Merlos-Suárez, A., Barriga, F. M., Jung, P., et al. (2011). The intestinal stem cell signature identifies colorectal cancer stem cells and predicts disease relapse. Cell Stem Cell. 10.1016/j.stem.2011.02.020.
162. Cao, C., Dong, Y., & Dong, Y. (2005). [Study on culture and in vitro osteogenesis of blood-derived human mesenchymal stem cells]. Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi, 19, 642–647.
163. Kassis, I., Zangi, L., Rivkin, R., et al. (2006). Isolation of mesenchymal stem cells from G-CSF-mobilized human peripheral blood using fibrin microbeads. Bone Marrow Transplant. 10.1038/sj.bmt.1705358.
164. Pino, A. M., Rosen, C. J., & Rodríguez, J. P. (2012). In Osteoporosis, differentiation of mesenchymal stem cells (MSCs) improves bone marrow adipogenesis. Biological Research. 10.4067/S0716-97602012000300009.
165. Rodríguez, J. P., Garat, S., Gajardo, H., Pino, A. M., & Seitz, G. (1999). Abnormal osteogenesis in osteoporotic patients is reflected by altered mesenchymal stem cells dynamics. Journal of Cellular Biochemistry. 10.1002/(SICI)1097-4644(19991201)75:3<414::AID-JCB7>3.0.CO;2-C
166. Rosen, C. J., & Bouxsein, M. L. (2006). Mechanisms of disease: is osteoporosis the obesity of bone? Nature Clinical Practice Rheumatology. 10.1038/ncprheum0070.
167. D’Ippolito, G., Schiller, P. C., Ricordi, C., Roos, B. A., & Howard, G. A. (1999). Age-related osteogenic potential of mesenchymal stromal stem cells from human vertebral bone marrow. Journal of Bone and Mineral Research. 10.1359/jbmr.1999.14.7.1115.
168. Gunawardene, P., Bermeo, S., Vidal, C., et al. (2016). Association between circulating osteogenic progenitor cells and disability and frailty in older persons: the Nepean osteoporosis and frailty study. The Journals of Gerontology Series A, Biological Sciences and Medical Sciences. 10.1093/gerona/glv190.
169. Yu, B., & Wang, C. Y. (2016). Osteoporosis: the result of an “aged” bone microenvironment. Trends Mol Med. 10.1016/j.molmed.2016.06.002.
170. Benisch, P., Schilling, T., Klein-Hitpass, L., et al. (2012). The transcriptional profile of mesenchymal stem cell populations in primary osteoporosis is distinct and shows overexpression of osteogenic inhibitors. PLoS One. 10.1371/journal.pone.0045142.
171. Marco, F., Milena, F., Gianluca, G., & Vittoria, O. (2005). Peri-implant osteogenesis in health and osteoporosis. Micron. 10.1016/j.micron.2005.07.008.
172. Heilmeier, U., Hackl, M., Skalicky, S., et al. (2016). Serum miRNA signatures are indicative of skeletal fractures in postmenopausal women with and without type 2 diabetes and influence of osteogenic and adipogenic differentiation of adipose-tissue-derived mesenchymal stem cells in vitro. Journal of Bone and Mineral Research. 10.1002/jbmr.2897.
173. Barry, F., & Murphy, M. (2013). Mesenchymal stem cells in joint disease and repair. Nature Reviews Rheumatology. 10.1038/nrrheum.2013.109.
174. Hermida-Gómez, T., Fuentes-Boquete, I., Gimeno-Longas, M. J., et al. (2011). Quantification of cells expressing mesenchymal stem cell markers in healthy and osteoarthritic synovial membranes. The Journal of Rheumatology. 10.3899/jrheum.100614.
175. Findlay, D. M., & Kuliwaba, J. S. (2016). Bone–cartilage crosstalk: a conversation for understanding osteoarthritis. Bone Research. 10.1038/boneres.2016.28.
176. Kalinkovich, A., & Livshits, G. (2015). Sarcopenia–The search for emerging biomarkers. Ageing Research Reviews. 10.1016/j.arr.2015.05.001.
177. Sousa-Victor, P., & Muñoz-Cánoves, P. (2016). Regenerative decline of stem cells in sarcopenia. Molecular Aspects of Medicine. 10.1016/j.mam.2016.02.002.
178. Sousa-Victor, P., Gutarra, S., García-Prat, L., et al. (2014). Geriatric muscle stem cells switch reversible quiescence into senescence. Nature. 10.1038/nature13013.
179. Fry, C. S., Lee, J. D., Mula, J., et al. (2015). Inducible depletion of satellite cells in adult, sedentary mice impairs muscle regenerative capacity without affecting sarcopenia. Nature Medicine. 10.1038/nm.3710.
180. Dennison, E. M., Sayer, A. A., & Cooper, C. (2017). Epidemiology of sarcopenia and insight into possible therapeutic targets. Nature Reviews Rheumatology. 10.1038/nrrheum.2017.60.
181. Snijders, T., Verdijk, L. B., & van Loon, L. J. C. (2009). The impact of sarcopenia and exercise training on skeletal muscle satellite cells. Ageing Research Reviews. 10.1016/j.arr.2009.05.003.
182. Emery, A. E. H. (1991). Population frequencies of inherited neuromuscular diseases-A world survey. Neuromuscular Disorders. 10.1016/0960-8966(91)90039-U.
183. Song, Y., Yao, S., Liu, Y., et al. (2017). Expression levels of TGF-β1 and CTGF are associated with the severity of Duchenne muscular dystrophy. Experimental and Therapeutic Medicine. 10.3892/etm.2017.4105.
184. mdx: what makes them different? European Journal of Human Genetics. 10.1038/ejhg.2016.16.
185. Dumont, N. A., Xin Wang, Y., & von Maltzahn, J. (2015). Dystrophin expression in muscle stem cells regulates their polarity and asymmetric division. Nature Medicine. 10.1038/nm.3990.
186. Marg, A., Escobar, H., Gloy, S., et al. (2014). Human satellite cells have regenerative capacity and are genetically manipulable. Journal of Clinical Investigation. 10.1172/JCI63992.
187. Wang, Y., Han, Z., Song, Y., & Han, Z. C. (2012). Safety of mesenchymal stem cells for clinical application. Stem Cells International. 10.1155/2012/652034.
188. Lu, X., & Zhao, T. (2013). Clinical Therapy using iPSCs: Hopes and Challenges. Genomics, Proteomics & Bioinformatics. 10.1016/j.gpb.2013.09.002.
189. Liu, X., Li, W., Fu, X., & Xu, Y. (2017). The immunogenicity and immune tolerance of pluripotent stem cell derivatives. Frontiers in Immunology. 10.3389/fimmu.2017.00645.